1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Post COVID-19 Condition, Unspecified: new trials by email Literature Review of Post COVID-19 Condition, Unspecified trials Research Report on Post COVID-19 Condition, Unspecified
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID stellate ganglion block with 0.5% bupivacaine - Post Acute COVID-19 Syndrome, Long COVID | Phase 1 | Completed | Jonathann Kuo, MD | 20 | 2023-01-03 | 2025-03-13 |
Autonomic Nervous System Diseases (1) · COVID-19 (1) · Dysautonomia like disorder (1) · Post-Acute COVID-19 Syndrome (1) · Shy-Drager Syndrome (1)
Basal Ganglia Diseases (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Chronic Disease (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Disease Attributes (1) · Hypotension (1) · Infections (1) · Lung Diseases (1) · Movement Disorders (1) · Multiple System Atrophy (1) · Nervous System Diseases (1) · Nidovirales Infections (1)
Bupivacaine (1)
United States (1)